Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more) Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Baudax Bio Inc (EM) BXRXQ

Healthcare Biotechnology
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical... see more

Current News (EXPM:BXRXQ)

Baudax Bio Announces Corporate Update

GlobeNewswire October 18, 2023

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

GlobeNewswire September 28, 2023

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

GlobeNewswire September 7, 2023

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

GlobeNewswire August 23, 2023

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire August 17, 2023

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire August 16, 2023

Baudax Bio Acquires TeraImmune, Inc.

GlobeNewswire June 30, 2023

Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000

GlobeNewswire June 7, 2023

Baudax Bio Announces Date of Reconvened Annual Meeting

GlobeNewswire June 6, 2023
View More News ››

Opinion & Analysis (EXPM:BXRXQ)

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Streetwise Reports February 24, 2020
View More Opinion ››

Bullboard Posts (EXPM:BXRXQ)

BXRX....Halted again on the way down

In PB mode now.....me no position Cheers and GLTA
Iseneschal - June 30, 2023

BXRX.....3rd scalp..... I'm done now

going camping ....Cheers !
Iseneschal - June 30, 2023

BXRX....Volume & price action..Love it

Here i go pumping..... But ...wouldn't surprise me to see this get to the DTL trend line..... somewhere around ~ $2
Iseneschal - June 30, 2023

BXRX..... Halted again....on the rising swell upward

This has a history of big intra-day swings  Trade accordingly ; )
Iseneschal - June 30, 2023

BXRX.....Ride the wave ; )

What a rip
Iseneschal - June 30, 2023

BXRX ....Now did you just see that !!!!!!!!!!!!!

WTF
Iseneschal - June 30, 2023
View more Bullboard ››

Boron One Holdings Inc.

Boron One Holdings Inc.

Boron One Holdings Inc. engages in the acquisition, exploration, and development of mineral properties in Serbia. The company ...
View More »

Podcasts